Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
Become a Member | Sign in
Home>News>This Article

Understanding Triglycerides’ Role in Coronary Disease

Published: Wednesday, October 09, 2013
Last Updated: Wednesday, October 09, 2013
Bookmark and Share
The study leverages new genetic data from a related genome-wide association study, suggests that lowering triglyceride levels through treatment may help reduce the risk of coronary heart disease.

A team led by Broad Institute researchers has found that triglycerides - the fats that our bodies burn for fuel - play a causal role in coronary artery disease (CAD), the most common form of heart disease and the leading cause of death in the United States. 

Every day, millions of vials of blood are drawn to assess patients’ risk for the disease. These tests measure three biomarkers, or factors in the blood known to be associated with CAD: low-density lipoproteins (LDL cholesterol), high-density lipoproteins (HDL cholesterol), and triglycerides. All three biomarkers are lipids – water-insoluble molecules that are among the structural and functional building blocks of living cells.

“The key question over the years about these biomarkers has been, which ones cause coronary artery disease and which ones are merely reflective of the disease process?” said Broad associate member Sekar Kathiresan, who led the study along with Broad senior associate member Mark Daly, associate member Ben Neale, and first author Ron Do, who is a postdoctoral fellow in Kathiresan’s lab. Kathiresan is also the director of preventive cardiology at Massachusetts General Hospital.

“The reason that question is important is not for prediction, because biomarkers are useful for predicting disease whether they are causal or not,” Kathiresan explained. “The reason we want to distinguish between these factors is for treatment. We really only want to attack the causes of the disease.”

LDL, the so-called "bad cholesterol," has already been proven to cause heart disease and is the target of the well-known, cholesterol-lowering drugs called statins. HDL, the "good cholesterol" once thought to directly reduce risk of CAD, has in recent studies shown no causal connection with coronary artery disease.

The role of triglycerides has remained a matter for debate. While elevated triglyceride levels are seen in patients with CAD, making it an effective biomarker, evidence that these blood fats play a causal role in the disease has been inconclusive, and treatments aimed at lowering triglyceride levels have not yet succeeded in reducing disease risk.

To determine whether triglycerides do, in fact, play a causal role in CAD, Kathiresan’s team looked at 185 variations in the genetic code that have been found to be associated with blood lipid traits. Such variations, called single nucleotide polymorphisims, or “SNPs,” are inherited from one or both parents and can affect the way an individual expresses a given trait.

The researchers looked at these SNPs in over 86,000 people and assessed the degree to which each SNP affected LDL, HDL, and triglyceride levels, as well as CAD risk. They then compared these effects. If SNPs that altered the level of a given biomarker also altered disease risk to the same degree, it could be assumed that the relationship between the biomarker and the disease was causal.

Kathiresan’s team previously applied this approach to LDL and HDL in studies that confirmed LDL’s causal role in heart disease, and cast doubt on any causal association between HDL and CAD. This new study, which relies on new genetic variants identified by the Global Lipids Genetic Consortium (GLGC) in a paper also published this week in Nature Genetics, confirms the previous findings while taking a fresh look at the role of triglycerides.

Kathiresan, who was also one of the leaders of the GLGC study, said that his team observed a pattern of association between triglycerides and CAD that resembled what they observed for LDL: the effects of these SNPs on triglyceride levels were highly associated with their effect on CAD risk, even after accounting for the potentially confounding effect of each SNP on HDL or LDL levels. The data strongly suggest that triglycerides are a causal factor in CAD.

Exactly how triglycerides may contribute to coronary artery disease is still undetermined. LDL cholesterol is known to cause CAD by contributing to the build-up of “plaque” along the artery walls. As these molecules are deposited, they block blood flow through the arteries, which can lead to heart attack. One hypothesis is that the lipoprotein particles that carry triglycerides in the blood stream (so-called triglyceride-rich lipoproteins) may deposit in the heart arteries in a manner similar to LDL.

The researchers suggests that, even as the exact causal mechanisms are worked out, targeting triglycerides for treatment may be an effective strategy for reducing heart disease risk.

“Clinically speaking, one of the ways to prevent a first heart attack or to reduce the risk of a second heart attack in someone who already has heart disease may be to treat patients with medicines that lower the levels of triglyceride-rich lipoproteins,” Katherisan said. “Some drugs that target triglycerides are already being tested; it is now a matter of finding the right mechanism of lowering triglycerides that will effectively reduce disease risk.”

The findings appear this week in Nature Genetics.

Other Broad researchers who contributed to this work include Chi Gao, Gina Peloso, Tõnu Esko, Pierre Fontanillas, Sailaja Vedantam, Joel Hirschhorn, and David Altshuler.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Diagnostics Breakthrough Brings Viral Sequencing to Doctors’ Toolkit
New screening tool produces up to 10,000-fold improvement in viral matches compared with traditional high-throughput methods.
Monday, September 28, 2015
GTEx: Useful Expression For Cancer Research
GTEx Project has recently published several papers reporting on findings from its two-year pilot phase.
Tuesday, May 26, 2015
Two Studies Identify A Detectable, Pre-Cancerous State In The Blood
Findings pave way for new lines of cancer research focused on detection and prevention.
Thursday, November 27, 2014
Dramatic Response And Resistance To Cancer Drug Traced
Sequencing reveals why thyroid tumor responded to, and eventually resisted, treatment.
Friday, October 10, 2014
Predicting Cancer’s Next Move
Research offers a new approach to studying drug resistance in cancer.
Monday, November 11, 2013
Better Living through Proteomics
As a patient facing illness, knowing what’s ailing you can bring peace of mind and, more importantly, can inform treatment decisions.
Monday, September 09, 2013
Bringing Out the Usual – and Unusual – Cancer Genomics Suspects
Several years ago, researchers sequencing lung cancer genomes encountered a number of red herrings.
Tuesday, June 18, 2013
Chemical Screen Points to New Line of Attack Against Neuroblastoma
In the war on neuroblastoma, the current chemical weaponry is reaching its limit.
Monday, June 10, 2013
Broad Institute, Dana-Farber and Novartis Collaborate to Develop Cancer Cell Line Encyclopedia
Scientists have written the 'Book of Cancer Knowledge' to aid future research into drug discovery and personalized medicine.
Friday, March 30, 2012
Work Flows from Advanced Large-Scale Methods for Measuring Proteins
Researchers have created the most comprehensive “parts list” to date for mitochondria, a compendium that includes nearly 1,100 proteins.
Thursday, July 17, 2008
New Tools Enable Large-Scale Studies of Gene Function
A molecular library created by a research team led by scientists at the Broad Institute of MIT and Harvard has promised to accelerate scientists' understanding of the genetics behind cancer.
Monday, April 10, 2006
Broad Institute Standardizes on Thermo’s MBS Satellite Thermal Cycler
215 additional MBS Satellite thermal cyclers purchased for large-scale genome sequencing and analysis.
Thursday, December 01, 2005
Scientific News
Chromosomal Chaos
Penn study forms basis for future precision medicine approaches for Sezary syndrome
Shaking Up the Foundations of Epigenetics
Researchers at the Centre for Genomic Regulation (CRG) and the University of Barcelona (UB) published a study that challenges some of the current beliefs about epigenetics.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Lung Repair and Regeneration Gene Discovered
New role for hedgehog gene offers better understanding of lung disease.
Mixed Up Cell Transportation Key Piece of ALS and Dementia Puzzle
Researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
New Hope for Personalized Treatment of Eczema
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Gene Expression: A Snapshot of Stem Cell Development
New genes found that regulate development of stem cells.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos